B2M overexpression correlates with malignancy and immune signatures in human gliomas
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-84465-6
Abstract: Because of the limited treatment strategy of gliomas, the key of diagnosis and treatment is finding new molecular biomarkers. Here, we explored the potential of β2-microglobulin (B2M) to serve as a hopeful candidate for immunotherapy… read more here.
Keywords: gliomas; overexpression correlates; b2m; b2m expression ... See more keywords